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Summary statement: The Arp2/3 complex stimulates formation of branched actin filament 
networks, and exhibits isoform diversity in mammals. We show how different Arp2/3 subunit 
isoforms contribute to differences in complex function. 
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Abstract 
The Arp2/3 complex regulates many cellular processes by stimulating formation of branched 
actin filament networks. Because three of its seven subunits exist as two different isoforms, 
mammals produce a family of Arp2/3 complexes with different properties that may be suited 
to different physiological contexts. To shed light on how isoform diversification affects Arp2/3 
function, we determined a 4.2 Å resolution cryo-EM structure of the most active human 
Arp2/3 complex containing ARPC1B and ARPC5L, and compared it with the structure of the 
least active ARPC1A-ARPC5-containing complex. The architecture of each isoform-specific 
Arp2/3 complex is the same. Strikingly, however, the N-terminal half of ARPC5L is partially 
disordered compared to ARPC5, suggesting that this region of ARPC5/ARPC5L is an 
important determinant of complex activity. Confirming this idea, the nucleation activity of 
Arp2/3 complexes containing hybrid ARPC5/ARPC5L subunits is higher when the ARPC5L 
N-terminus is present, thereby providing insight into activity differences between the different 
Arp2/3 complexes. 
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Introduction 
 
The Arp2/3 complex is evolutionarily conserved and built from two actin related proteins 
(Arp2 and Arp3) and five other protein subunits (ARPC1-5) (Molinie and Gautreau, 2018, 
Goley and Welch, 2006). It plays an essential role in many cellular processes, most notably 
cell migration (Goley and Welch, 2006, Krause and Gautreau, 2014), and also has newly 
identified roles in DNA repair (Caridi et al., 2018, Schrank et al., 2018). When activated by a 
nucleation promoting factor such as WAVE or WASP, the Arp2/3 complex is unique in its 
ability to assemble branched actin networks by stimulating new filament growth from the side 
of existing actin filaments (Campellone and Welch, 2010).  
 
Until recently, the Arp2/3 complex has been considered as a single entity. However, in 
mammals, Arp3, ARPC1 and ARPC5 are present as two isoforms - Arp3, Arp3B, ARPC1A, 
ARPC1B, ARPC5 and ARPC5L - that share 91, 67 and 67% sequence identity respectively 
(Abella et al., 2016, Pizarro-Cerda et al., 2017). This raises the question as to whether 
different Arp2/3 complexes have evolved unique properties that are adapted to their 
particular cellular, developmental or physiological roles. Recent work has shown that the 
ARPC1 and ARPC5 isoforms differentially affect the actin nucleating properties of the Arp2/3 
complex and the stability of the branched filament networks it generates (Abella et al., 2016). 
Furthermore, tissue-specific expression patterns of subunit isoforms, together with isoform-
specific susceptibility to disease-causing point mutations, point to distinct physiological roles 
for particular Arp2/3 isoforms in nuclei positioning in skeletal muscle (Roman et al., 2017), 
as well as cytotoxic T lymphocyte maintenance and activity (Brigida et al., 2018, Kuijpers et 
al., 2017, Randzavola et al., 2019, Somech et al., 2017, Volpi et al., 2019, Roman et al., 
2017, Kahr et al., 2017). 
 
Currently, the available high-resolution structures of mammalian Arp2/3 cannot address the 
role of isoform-specified diversity. Using natively purified proteins, only a single isoform 
combination - ARPC1B-ARPC5 - of mammalian Arp2/3 has been visualised (for example, 
the first structure described by (Robinson et al., 2001); this combination was shown to have 
intermediate nucleation activity (Abella et al., 2016). To begin to understand how subunit 
composition affects the properties of human Arp2/3 complexes, we used recombinant 
protein expression and cryo-electron microscopy (cryo-EM) to determine the structure of the 
most active human Arp2/3 complex, containing ARPC1B and ARPC5L subunits, referred to 
here as Arp2/3-C1B-C5L. We compared it with the structure of a complex containing 
ARPC1A and ARPC5 (Arp2/3-C1A-C5), which has the lowest activity (Abella et al., 2016). 
Our structures show isoform-specific differences in the N-terminus of ARPC5/5L and 
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suggest that these structural variations mediate different activities. Using protein 
engineering, we show that inclusion of the N-terminus of ARPC5L in hybrid Arp2/3 
complexes enhances their actin nucleation activity, thereby showing how different Arp2/3 
subunit isoforms contribute to differences in complex activation and function. 
 
Results & Discussion 
 
Overview of human Arp2/3 complex structure 
 
We first determined the 4.2Å resolution structure and calculated a pseudo-atomic model of 
the most active human Arp2/3 complex Arp2/3-C1B-C5L (Fig. 1; Table 1; Fig. S1A-C) 
(Abella et al., 2016). The complex shows the characteristic triangle shape - ~150 Å x130 Å 
and ~100 Å thick - seen in previous crystallographically determined structures of Arp2/3 
complex purified from bovine brain and yeast (Robinson et al., 2001, Nolen and Pollard, 
2007, Nolen and Pollard, 2008, Nolen et al., 2009). As observed in these previous 
structures, the intertwined ARPC2/4 subunits (Fig. 1A,B, light/dark blue) form the platform 
for complex assembly, with Arp3/ARPC3 (Fig. 1A,B, orange/magenta) and 
Arp2/ARPC1B/ARPC5L (Fig. 1A,B, red/green/yellow)) constituting distinct protrusions. Apart 
from a few residues at the N- and C-termini, the ARPC1B, C2, C3 and C4 subunits are 
completely visualised. Similarly, Arp3 is almost completely represented in the cryo-EM 
density. In contrast, while subdomains 3 and 4 of Arp2 are well ordered and at a similar 
resolution to the rest of the reconstruction, density corresponding to subdomain 1 is present 
but poorly defined and subdomain 2 is even less distinct (Fig. 1B). In addition, although 
density corresponding to the 2 C-terminal α-helices of ARP5CL lies adjacent to ARPC4, 
there is a sharp fall-off in the strength of the cryo-EM density for the rest of the subunit 
further from the body of the complex (described in detail below). The regions of different 
flexibility within the complex also manifest in the variations in local resolution of the 
reconstruction (Fig. S1D). 
 
Conformation of ATP-bound Arp3 and Arp2 
 
ATP is a key regulator of Arp2/3 complex activity (Le Clainche et al., 2001, Nolen and 
Pollard, 2007, Ingerman et al., 2013, Rodnick-Smith et al., 2016, Martin et al., 2006), and 
density corresponding to ATP, assigned based on comparison with previously determined 
structures, is bound to Arp3 in the Arp2/3-C1B-C5L reconstruction (Fig. 2A, B). Consistent 
with this, the Arp3 nucleotide binding pocket adopts a closed conformation as defined 
previously (Nolen and Pollard, 2007), such that the outer portions subdomains 2 and 4 of 
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Arp3 are closer together than in structures with no bound nucleotide (e.g. 1K8K; Fig. 2C). 
Furthermore, the conformation of human Arp3 in our reconstruction is similar to that of 
previously determined ATP-bound bovine Arp3 in this region (Fig. 2D). 
 
In Arp2, density corresponding to bound nucleotide, again assigned based on comparison 
with previously determined structures, is present at the junction of subdomains 3 and 4 (Fig. 
2E, F). Density from Arp2 subdomain1 exhibits some ordering immediately adjacent to the 
nucleotide density, consistent with the role of this region in nucleotide binding, whereas only 
low-resolution density is present for most of subdomains 1 and 2, and is of insufficient 
quality for models to be calculated. The overall weak 3D density of this region of Arp2 is 
consistent with the conformational variability seen in 2D classes (Fig. 2G), and with the 
flexibility that has been previously observed in Arp2/3 crystal structures (Robinson et al., 
2001, Nolen and Pollard, 2007, Nolen and Pollard, 2008, Nolen et al., 2009). These data all 
support the idea that flexibility is intrinsic to this region of the Arp2/3 complex in the presence 
of ATP and that ATP binding does not induce large-scale conformational changes in the 
complex (Espinoza-Sanchez et al., 2018), in contrast to the large ATP-induced 
rearrangements previously proposed by (Rodnick-Smith et al., 2016). Earlier low-resolution 
EM characterizations of Arp2/3 probably also captured the dynamic properties of this region 
rather than activated states of the complex (Rodal et al., 2005, Sokolova et al., 2017). It is 
also possible that interaction with the grid surface in negative stain experiments may cause 
additional ordering of Arp2 subdomains 1 and 2 (Espinoza-Sanchez et al., 2018), in contrast 
to what we observe in our cryo-EM experiments. 
 
The previously determined structure of inhibitor-bound Arp2/3 provides the most complete 
structural view of Arp2 (Luan and Nolen, 2013) in which subdomain 2 of Arp2 lies close to 
the loop connecting helix-α7 and -α8 in Arp3. Interestingly, although the Arp2 density in our 
uninhibited complex is relatively weak, the connectivity with Arp3 is not the same as in the 
inhibited structure, but rather occurs via helix-α9 (Fig. 2H). This supports the idea that 
Arp2/3 complex inhibition operates at least in part by restricting the movements of otherwise 
flexible regions of Arp2 and implies that flexibility in this region is important for subsequent 
steps in its activation. The connectivity between Arp2 and Arp3 in our reconstruction may 
represent a route of allosteric communication that is part of the activation process for the 
complex, a route that is blocked by inhibitor binding. Evidence of such allosteric 
communication between Arp2 and Arp3 is also provided by the recent cryo-EM 
reconstruction of NPF-bound human Arp2/3-C1B-C5 complex (Zimmet et al., 2020), in which 
subdomain 2 of Arp2, while visible, remains one of the most flexible parts of the structure. 
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To investigate how general these observations are for cryo-EM-determined reconstructions 
of Arp2/3 complexes, we also calculated the 3D reconstruction of human Arp2/3 complex 
containing ARPC1A and ARPC5 subunits (Fig. 3). This reconstruction has a slightly lower 
overall resolution (4.5 Å; Fig. S2A), its constituent particles also exhibit non-isotropic angular 
orientations (Fig. S2B) and the reconstruction shows non-isotropic variation in local 
resolution (Fig. S2C). However, it is clear from this structure that the overall conformation of 
the Arp2/3-C1A-C5 reconstruction is extremely similar to that of Arp2/3-C1B-C5L, apart from 
the density corresponding to ARPC5/C5L (see below). In particular, in each complex Arp2 
and Arp3 are similarly organized with respect to each other, although subdomains 1 and 2 in 
Arp2 are even more flexible in the Arp2/3-C1A-C5 structure compared to Arp2/3-C1B-C5L 
(Fig. 3A, B and Fig. S2D with Fig. 1A,B and Fig. 2G). This supports the idea that 
subdomains 1 and 2 of Arp2 are intrinsically flexible even in the presence of activating 
nucleotide, and that this flexibility is important for subsequent activation steps in the 
presence of additional ligands. The overall conformational similarity of these two isoform-
specific complexes - which have been shown to have very different actin assembly 
promoting activities both in vitro and in cells (Abella et al., 2016) - implies that the isoform-
specific differences observed are not mediated by fundamentally different architectures of 
the complex, but rather by alternative regulatory effects conferred by isoform-specific 
residues. 
 
Isoform specific subunit conformation and determinants of activity 
 
To further investigate the differences between isoform-specific human Arp2/3 complexes, 
the location of partially- or non-conserved sequence variation between ARPC1A and 
ARPC1B were mapped onto the ARPC1B structure (Fig. 4A, left, green spheres; Fig. S3A). 
These isoform-specific-sites map primarily to the surface of the ARPC1 subunit rather than 
the β-propeller structural core (Fig. 4A), consistent with the overall similar structures of each 
isoform. This suggests that Arp2/3 activity differences arising from ARPC1 isoforms are 
mediated either by the interactions with ARPC4 and ARPC5 within the complex itself, and/or 
with other binding partners, including the mother actin filament during branch formation. 
 
Loss-of-function mutations of ARPC1B give rise to multisystem inflammatory and 
immunodeficiency diseases (Brigida et al., 2018, Kahr et al., 2017, Kuijpers et al., 2017, 
Randzavola et al., 2019, Somech et al., 2017, Volpi et al., 2019), similar to Wiskott-Aldrich 
syndrome that is caused by mutations in the Arp2/3 activator WASP (Bosticardo et al., 
2009). While some patients carry mutations causing premature protein termination and total 
loss of ARPC1B protein, four point mutations – W104S, A105V, V208F and A238T – have 
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also been observed in patients (Brigida et al., 2018, Kahr et al., 2017, Volpi et al., 2019) 
(Fig. 4A, right, purple spheres). W104, A105 and V208 are located in the core of the 
ARPC1B subunit β-propeller fold and these mutations likely destabilizes its tertiary fold, 
causing severely reduced protein levels in patients (Kahr et al., 2017). Conversely, A238T is 
more peripheral in the structure indicating that more than one disease mechanism may be in 
play. Although some of these patients show increased levels of ARPC1A, the activity of this 
isoform is insufficient to substitute for lack of functional ARPC1B, consistent with the idea 
that Arp2/3 complex subunit diversity has been tuned for particular physiological contexts.  
 
The biggest difference between our two Arp2/3 cryo-EM reconstructions is the ARPC5 
subunit (Fig. 4B). In the Arp2/3-C1A-C5 structure, density corresponding to the helices of 
ARPC5 is clearly visible (Fig. 4B, right), as is the N-terminus of the subunit that extends to 
contact the barbed end cleft of Arp2 (Fig. 4C, right). This was also the case in the Arp2/3-
C1B-C5 complex reconstruction of (Zimmet et al., 2020). In the Arp2/3-C1B-C5L 
reconstruction, however, density corresponding to ARPC5L is less prominent (Fig. 4B, left). 
Density corresponding to the ARPC5L C-terminal helix-α7 is present and forms the major 
contact with the body of the Arp2/3 complex via ARPC4; at lower thresholds, density 
corresponding to helix-α5 and –α6 are also visible (Fig. 1B, right). However, the N-terminal 
half of this subunit, including connectivity to Arp2, is not visible even at low thresholds (Fig. 
4C, left). In principle, this could be due to variable ARPC5L protein occupancy in the 
complex, but the well-defined density of helix-α7 at the interface with ARPC4 suggests this is 
not the case. 
 
The C-terminal portion of ARPC5 - visible in both isoform reconstructions - corresponds to 
regions of greatest sequence similarity between the isoforms and between organisms, 
whereas the N-terminal region is more divergent (Fig. S3B). Our structures suggest the 
intriguing possibility that the higher activity of Arp2/3-C1B-C5L complexes (Abella et al., 
2016) may be due to the intrinsically more flexible attachment of ARPC5L N-terminus to the 
complex. To test this idea, we engineered ARPC5/C5L protein hybrids, in which their N-
terminal regions were swapped (Fig. 5A-C; Fig. S3B), and tested their actin nucleation 
activity in the context of the lowest activity Arp2/3-C1A complex. Consistent with the 
prediction arising from our structures, the hybrid complex containing the N-terminal region of 
ARPC5L was more active than that containing the equivalent region of ARPC5 (Fig. 5D). 
 
We therefore suggest that while the C-terminus of ARPC5 is closely associated with the 
body of Arp2/3, the role of its N-terminus is to contribute to regulation of complex activation: 
when contacting Arp2, the complex is held in an inactive conformation, while priming of the 
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complex involves release of these contacts and conformational restraints between the 
subunits. With its looser, less structured N-terminal connectivity, human ARPC5L-containing 
complexes are intrinsically more able to undergo activator-induced conformational changes, 
and may also adopt alternative conformations in the activated complex (Dalhaimer and 
Pollard, 2010). All currently available X-ray crystal structures of mammalian Arp2/3 
complexes contain the ARPC5 isoform and most of these structures fully visualize ARPC5; 
however, some also exhibit ARPC5 N-terminal conformational variability. Together with 
lower resolution negative stain EM analysis of S. cerevisiae Arp2/3 complexes (Martin et al., 
2005) and NPF-bound S. pombe Arp2/3 complex (Espinoza-Sanchez et al., 2018), these 
observations support the wider functional relevance of the dynamics of the ARPC5 N-
terminus in Arp2/3 activation revealed in our cryo-EM reconstructions.  
 
The overall conformations of our ATP-bound Arp2/3 cryo-EM structures are similar to 
previously determined X-ray crystallography structures of natively purified bovine Arp2/3 
complexes (Nolen et al., 2004, Nolen and Pollard, 2007). Earlier lower resolution negative 
stain EM studies of Arp2/3 complex have described a range of conformational changes in 
the Arp2/3 complex in response to ATP binding that likely reflect the intrinsic flexibility of 
portions of the unactivated complex, especially within Arp2 (Rodal et al., 2005, Sokolova et 
al., 2017). Thus, rather than inducing major conformational changes in the complex, 
available structures of Arp2/3 together with biophysical measurements point to the role of 
ATP binding in potentiating subsequent conformational changes induced by other activating 
factors, including nucleation promoting factors and binding to the mother filament (Goley and 
Welch, 2006, Kiselar et al., 2007, Luan et al., 2018, Martin et al., 2005, Zimmet et al., 2020). 
Our results set the stage for cryo-EM structure determination of Arp2/3 complexes bound by 
nucleation promoting factors, promising insights concerning steps of Arp2/3 activation - 
including isoform-dependent modulation of complex activation - in the future. 
 
 
Materials and Methods 
 
Cryo-EM grid preparation and data collection 
Arp2/3-C1B-C5L and Arp2/3-C1A-C5 complexes were prepared using the multibac 
expression system consisting of three pFL vectors (pFL–ARPC2–Arp3; pFL–ARPC4–
ARPC1A or C1B–STREP; and pFL–ARPC3–ARP2–ARPC5 or C5L) as described previously 
(Abella et al., 2016). They were diluted to 0.2-0.3 mg/ml in MOPS buffer (20 mM MOPS pH 
7.0, 100 mM KCl, 2mM MgCl2, 5 mM EGTA, 1 mM EDTA, 0.5 mM DTT, 0.2 mM ATP) and 4 
µl were applied to glow-discharged 1.2/1.3 holey gold grids (Quantifoil) before plunge 
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freezing in liquid ethane using a Vitrobot (FEI/Thermo Fisher Scientific) operating at room 
temperature and 100% humidity. Data for the Arp2/3-C1B-C5L complexes were collected at 
the UK National Electron Bio-imaging Centre (eBIC) at the Diamond Synchrotron using EPU 
on a Titan Krios microscope (FEI//Thermo Fisher Scientific) operating at 300 kV, and 
recorded on a K2 direct electron detector equipped with a Quantum energy filter (Gatan), 
with a pixel size of 1.06 Å/px. Two movies per hole were collected using a total dose of 60 e-
/Å2 each over 20 frames with 8 s exposure, and with a defocus range of -1.5 – -3.5 µm. Data 
for the Arp2/3-C1A-C5 complexes were collected manually on a Polara microscope 
(FEI/Thermo Fisher Scientific) operating at 300kV, and recorded on a K2 direct electron 
detector equipped with a Quantum energy filter (Gatan), with a pixel size of 1.09 Å/px. A 
total dose of 59 e-/Å2 per movie over 33 frames with 10 s exposure, and with a defocus 
range of -1.5 – -3.5 µm. 
 
For movie processing, all frames were aligned with using MotionCor2 (Zheng et al., 2017) 
and CTF was estimated with ctffind4 (Rohou and Grigorieff, 2015). Each dataset was 
processed independently using the RELION beta-version 2.0 (Kimanius et al., 2016). For the 
Arp2/3-C1B-C5L dataset, 1,547,329 particles were picked automatically from 3039 
micrographs in RELION v1.4 and v2.0 (Kimanius et al., 2016, Scheres, 2012), with a box-
size of 240 x 240 pixels. After iterative cleaning of the particles using 2D classification and 
particle sorting, 384,330 particles remained. These were subjected to a first 3D refinement 
using a crystal structure of the bovine ARP2/3 complex (PDB: 3DXM (Nolen et al., 2009) 
converted to EM density in EMAN (Ludtke et al., 1999) and filtered to 20 Å as an initial 
reference. The resulting initial reconstruction was used as a reference for several further 
rounds of 2D and 3D classification in RELION. The final 3D-reconstruction containing 
101,606 particles, was calculated from dose-weighted data and was automatically B-factor 
sharpened in RELION using with a B-factor of -151 (Scheres, 2012). The final overall 
resolution of the masked reconstruction was 4.2 Å (0.143 gold-standard-FSC). For the 
Arp2/3-C1A-C5 dataset, a similar procedure was followed: 697, 272 particles were picked 
from 1221 micrographs with a box-size of 256 x 256 pixels. After iterative cleaning of the 
particles using 2D classification and particle sorting, 405,152 particles remained. Because of 
the highly preferred orientation of particles in this dataset, particles with over-represented 
orientations were removed by 2D and 3D classification. The final 3D-reconstruction 
containing 130,973 particles was calculated from dose-weighted data and was automatically 
B-factor sharpened in RELION using with a B-factor of -179 (Scheres, 2012). The final 
overall resolution of the masked reconstruction was 4.5 Å.   
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Model building  
An initial model of Arp2/3-C1B-C5L was created using coordinates from PDB file 1K8K, and 
was rigid-body docked to the cryo-EM map using Chimera (Pettersen et al., 2004). 
Additional elements including the nucleotides from PDB file 4XF2 were added, before the 
bovine sequences from these structures were altered to human. Secondary structure-based 
rigid bodies were described with Ribfind (Pandurangan and Topf, 2012), before 
a combination of conjugate gradient energy minimisation and molecular dynamics fitting of 
the model into the map was undertaken with Flex-EM (Topf et al., 2008), part of the CCP-
EM suite (Burnley et al., 2017). The final model was processed using real space refinement 
in Phenix (Adams et al., 2010), for which a refinement resolution cutoff of 5 Å was used. 
Molprobity (Chen et al., 2010) was utilised to validate the geometry of the resultant model, 
which was then improved by manual inspection and local refinement of poor areas in Coot 
(Emsley et al., 2010), with Ramachandran and secondary structure restraints utilised. 
Because the Arp2/3-C1A-C5 reconstruction showed substantial non-isotropic resolution, a 
separate model for this structure was not calculated. Instead, the refined Arp2/3-C1B-C5L 
model was rigidly docked into the Arp2/3-C1A-C5 density, the ARPC5 model was replaced 
with that from 1K8K and its docking was locally refined. A full validation report for the atomic 
model was generated in phenix v1.17.1-3660 (Table 1). 
 
Production of ARPC5/C5L hybrid complexes  
ARPC5/C5L hybrid-containing complexes were designed by replacing residues 1-95 of C5L 
with 1-93 of C5, while for ARPC5L/C5 residues 96-153 of C5L were replaced with 94-151 of 
C5 (Fig. 5A). DNA corresponding to the hybrids were obtained from GeneArt Gene synthesis 
(Thermo Scientific), which were cloned into pFL vector to obtain pFL-ARPC5/C5L using 
BamHI/NotI sites and pFL-ARPC5L/C5 using XhoI/XmaI sites, respectively. pFL-
ARPC5/C5L was digested using BstZ17I/AvrII and the resulting insert was ligated into pFL-
ARPC3-ACTR2 that was linearized using BstZ17I/SpeI, to create pFL-ARPC3-ACTR2-
ARPC5/C5L. pFL-ARPC5L/C5 was digested using BstZ17I/PmeI and the insert was ligated 
into pFL-ARPC3-ACTR2 that was linearized with BstZ17I, to generate pFL-ARPC3-ACTR2-
ARPC5L/C5. The expression in Sf21 insect cells and protein purification of ARP2/3 
complexes containing the hybrids was performed as previously described (Fig. 5B) (Abella 
et al., 2016). Gel band quantification was performed using Fiji (Schindelin et al., 2012). To 
validate expression of the hybrids, Near-infrared Western immunoblot using Odyssey CLx 
detection system (Li-COR) was performed on the purified complexes with the following 
antibodies: Arp3 (Sigma A5979, Mouse), ARPC5L (Abcam ab169763, Rabbit), ARPC1A 
(Sigma HPA004334, Rabbit), and ARPC5 (Santa Cruz sc-166760, Mouse) (Fig. 5C).  
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Actin nucleation assays 
Recombinant GST-tagged VCA domain of human N-WASP (391-505) was expressed in 
E.Coli Rosetta 2 (DE3) and purified by affinity chromatography over a Sepharose 4B GSH 
affinity column (GE healthcare) followed by gel filtration over a Hiload Superdex 200 column 
(GE healthcare). Skeletal muscle actin was purified from rabbit muscle acetone powder 
following the protocol described in (Wioland et al., 2017). Pyrenyl-actin was made by 
labeling actin with N(1-pyrene)-iodoacetamide (Thermo Fisher). 
 
Actin assembly was detected by the change in pyrenyl-actin fluorescence using a Safas 
Xenius spectrofluorimeter (Safas) at room temperature. 1 μL of 0.2 μM Arp2/3, 1 μL of 0.8 
μM VCA and 8 μL of 20xKME (4 mM EGTA, 20 mM MgCl2, 1 M KCl) were mixed with 110 
µL of G-buffer (10 mM Tris HCl pH 7.0, 0.2 mM ATP, 0.1 mM CaCl2, 1 mM DTT). 40 μL of 8 
μΜ Mg-ATP-G-actin (5% pyrene labeled) was added to this protein solution and mixed 
rapidly. The fluorescence signal was recorded immediately, and until the curves reached the 
steady-state plateau. The fluorescence intensity was normalised using I(t)=(Iobs(t)-Imin)/(Imax-
Imin) where Imin, the average of the ten lowest data points, refers to the signal intensity before 
actin started to polymerise and Imax, the average of the ten highest data points, refers to the 
signal intensity at steady-state. The experiments were repeated four times, giving similar 
results. The different data sets were not combined.    
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 Figures 
 
 
Figure 1. The cryo-EM structure of the human Arp2/3 ARPC1B-ARPC5L complex. 
 
(A) Left, Overview of the cryo-EM reconstruction of Arp2/3-C1B-C5L with the docked model 
in the density, viewed and coloured as originally presented by (Robinson et al., 2001): Arp2: 
red; Arp3: orange; ARPC1B: green; ARPC2: cyan; ARPC3: magenta; ARPC4: light blue; 
ARPC5L: yellow; Right, same view of the reconstruction with a ~8 Å low-pass filter applied 
showing more flexible regions of the complex at lower resolution; 
(B) Left, 180º rotated view compared to (A) of the Arp2/3-C1B-C5L reconstruction and 
model; Right, same view of the reconstruction with a ~8 Å low-pass filter applied showing 
more flexible regions of the complex at lower resolution, which includes flexible connectivity 
between Arp2 and Arp3 (red arrow) and parts of ARPC5L; sd = subdomains of Arp2. 
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Figure 2. Nucleotide binding sites of Arp3 and Arp2 in Arp2/3-C1B-C5. 
 
(A) Cryo-EM reconstruction and model of nucleotide binding pocket of Arp3 with density 
corresponding to bound ATP indicated (dotted black oval); 
(B) Ribbon depiction of the Arp3 model with density corresponding to bound nucleotide 
shown in surface representation. This density is the calculated difference between our cryo-
EM reconstruction and simulated density of the atomic model without nucleotide at 
equivalent resolution, calculated using Chimera. This supports the conclusion that ATP is 
bound to Arp3; 
(C) Conformation of the nucleotide binding pocket of ATP-bound Arp3 in Arp2/3-C1B-C5L 
aligned (on subdomain 3) with a previously determined structure of nucleotide-free Arp2/3 
(PDB 1K8K), showing closure of the pocket in the presence of bound nucleotide; 
(D) Conformation of the nucleotide binding pocket of ATP-bound Arp3 aligned (on 
subdomain 3) with a previously determined structure of ATP-bound Arp2/3 (2P9S; (Nolen 
and Pollard, 2007)), showing equivalent closure of the pocket in the presence of bound 
nucleotide compared to the absence of nucleotide; 
(E) Cryo-EM reconstruction and model of nucleotide binding pocket of Arp2 with visible 
subdomain regions labelled and density corresponding to bound ATP indicated (dotted black 
oval); 
(F) Ribbon depiction of the Arp2 model with density corresponding to bound nucleotide 
shown in surface representation. This density is the calculated difference between our cryo-
EM reconstruction and simulated density of the atomic model without nucleotide at 
equivalent resolution, calculated using Chimera. This supports the conclusion that ATP is 
bound to Arp2; 
(G) 2D class averages of Arp2/3-C1B-C5L showing views corresponding to Fig. 1A (left 
panels) and Fig. 1B (right panels) illustrating the variable density corresponding to 
subdomain 2 of Arp2 (red arrows) and to ARPC5L (yellow arrows). ARPC2 is also labelled 
for reference (blue arrows). 
(H) Arp2 in the GMF-inhibited Arp2/3 (PDB 4JD2, in tan) (Luan and Nolen, 2013) is shown 
aligned with Arp2 (red) in Arp2/3-C1B-C5L within the low-pass filtered cryo-EM density. As 
previously shown, in the Arp2/3-C1B-C5L reconstruction Arp2 subdomain 2 is flexibly 
connected to Arp3 helix-α9 (orange arrow), whereas the well-defined structure of the Arp2 
subdomain 2 in the GMF-inhibited structure adopts a different conformation which protrudes 
from the EM density (tan asterisk). For clarity, other subunits within the GMF-inhibited 
complex are not shown. sd = subdomains of Arp2 
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Figure 3. The cryo-EM structure of the human Arp2/3-ARPC1A-ARPC5 complex. 
 
(A) Left, cryo-EM reconstruction of Arp2/3-C1A-C5; right, same view with a ~8 Å low-pass 
filter applied to potentially reveal more flexible regions of the complex at lower resolution. 
The docked model is coloured as in previous figures: Arp2: red; Arp3: orange; ARPC2: cyan; 
ARPC3: dark pink; ARPC4: blue, except that ARPC1A is dark green and ARPC5 is pale 
yellow; 
(B) Left, 180º rotated view compared to (A) of the Arp2/3-C1A-C5 reconstruction and model; 
right, same view of the reconstruction with a ~8 Å low-pass filter applied; sd = subdomains of 
Arp2. 
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Figure 4. Isoform-mediated differences in human Arp2/3 complexes. 
(A) Left, location of non-conserved sequence variation between human ARPC1A and 
ARPC1B (green spheres) and location of disease-causing ARPC1B point mutations (purple 
spheres) mapped onto ARPC1B; right, cross section through ARPC1B; 
(B) Left, density corresponding to ARPC5L, showing the incomplete density for this subunit 
apart from helix-α7 adjacent to ARPC4; Right, density corresponding to ARPC5, showing the 
near complete density for this subunit 
(C) Left, 90º rotated view compared to B, left of ARPC5L showing the incomplete density for 
this subunit and lack of connectivity to Arp2; Right, 90º rotated view compared to B, right of 
ARPC5, showing the clear density for most of the subunit, including its N-terminal tether to 
Arp2. 
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Figure 5. Activity of ARPC5/C5L hybrid complexes support a role for ARPC5/C5L N-
terminus in defining functional differences between Arp2/3 subunit isoforms. 
 
(A) Schematic and nomenclature of ARPC5/C5L hybrids. 
(B) Coomassie-stained gel of purified recombinant Arp2/3 complexes containing ARPC1A 
together with ARPC5, ARPC5L or their hybrids. Gel band quantification of ARPC5, ARPC5L 
and the hybrids normalised to ARPC2 showed the same ratio in all cases, consistent with 
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equivalent subunit occupancy (ARPC5/ARPC2 = 0.52 ±0.04; ARPC5L/ARPC2 = 0.52±0.09; 
C5C5L/ARPC2 = 0.46±0.04; C5LC5/ARPC2 = 0.46±0.04 (mean ± standard deviation, n=3, 
technical replicates); 
(C) Immunoblot analysis of purified recombinant Arp2/3 complexes used in this study. 
(D) In vitro polymerisation of 2µM pyrene-actin (5% labeled), either alone (black curve) or in 
the presence of 5 nM VCA and 1.25 nM of Arp2/3-C1A with the indicated ARPC5 isoforms 
or hybrids (named as in panel A) shows differences in actin assembly according to the 
ARPC5/5L N-terminal region present. The curves shown here come from one representative 
experiment, which was repeated four times, giving similar results. The time at half-maximum, 
normalized to that of the ARPC5L isoform, is 1.27 ± 0.06 for ARPC5, 1.32 ± 0.10 for 
ARPC5/C5L, and 1.01 ± 0.06 for ARPC5L/C5 (average ± standard error, n=4, technical 
replicates). 
 
Table 1. Model refinement statistics and geometries. 
 
  
Model Arp2/3-C1B-C5L Arp2/3-C1A-C5 
MolProbity score  
Clash score       
Bond mean RMSD (Å)      
Angle mean RMSD (°)        
Rotamer outliers (%)       
1.99 
11.1 
0.007 
1.238 
0.53 
3.21 
46.89 
0.018 
3.029 
8.23 
Ramachandran 
Outliers (%)        
Allowed (%)        
Favoured (%)       
0.30 
6.2 
93.51 
0.85 
4.49 
94.65 
Map/Model correlation coefficient 
CC (mask)        0.78 n/a (backbone only) 
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Cryo-EM of human Arp2/3 complexes provides structural insights 
into actin nucleation modulation by ARPC5 isoforms  
 
 
 
Ottilie von Loeffelholz, Andrew Purkiss, Luyan Cao, Svend Kjaer, Naoko Kogata, Guillaume 
Romet-Lemonne, Michael Way, & Carolyn A. Moores 
 
SUPPLEMENTARY FIGURES 
  
Biology Open (2020): doi:10.1242/bio.054304: Supplementary information
B
io
lo
gy
 O
pe
n 
• 
S
up
pl
em
en
ta
ry
 in
fo
rm
at
io
n
 at Birkbeck College on July 20, 2020http://bio.biologists.org/Downloaded from 
 2 
 
 
 
 
 
 
 
Figure S1. Evaluation of the resolution of the Arp2/3-C1B-C5L reconstruction. 
 
(A) FSC curve of the Arp2/3-C1B-C5L reconstruction, showing the 0.143 criteria resolution 
cut-off = 4.2 Å; 
(B) Example sections of the Arp2/3-C1B-C5L cryo-EM density showing a β-sheet region of 
ARPC2 (top) and α-helical regions of ARPC2 and ARPC4 (bottom) illustrating the quality of 
the best regions of the reconstruction; 
(C) Orientation distribution of particles used for the final 3D reconstruction; the most 
common view corresponds to that depicted in Figure 1A; 
(D) Local resolution depiction of the Arp2/3-C1B-C5L reconstruction calculated using RELION, 
showing views equivalent to Figure 1A (left) and Figure 1B (right). 
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Figure S2.  Evaluation of the resolution of the Arp2/3-ARPC1A-ARPC5 reconstruction. 
 
(A) FSC curve of the Arp2/3-C1A-C5 reconstruction, showing the 0.143 criteria resolution 
cut-off = 4.5Å; 
(B) Orientation distribution of particles used for the final 3D reconstruction; the most 
common view corresponds to that depicted in Figure 3A; 
(C) Local resolution depiction of the Arp2/3-C1A-C5 reconstruction calculated using RELION, 
showing views equivalent to panel A (left) and panel B (right). 
(D) 2D class averages of Arp2/3-C1A-C5 showing views corresponding to Figure 3A (upper 
2 classes) and Figure 3B (bottom panel) illustrating the variable density corresponding to 
subdomain 2 of Arp2 (red arrows) but the consistent density corresponding to ARPC5 
(yellow arrows); this contrasts to that seen in the Arp2/3-C1B-C5L complex. ARPC2 (blue 
arrow) is also indicated for reference. 
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Figure S3. Sequence alignment of ARPC1 and ARPC5. 
(A) Sequence alignment of human ARPC1 isoforms. Sequences were aligned using T-
Coffee (Notredame et al., 2000) and the alignment was prepared using Chimera (Pettersen 
et al., 2004) with the Clustal X colour scheme. The position of immunodeficiency syndrome-
associated point mutations in ARCP1B – W104S, A105V, V208F and A238T – are indicated 
with purple asterisks (Kahr et al., 2017). 
(B) Sequence alignment of ARPC5 including the two human isoforms (Hs_C5L, Hs_C5), and 
C5 sequences from S. cerevisiae (Sc_S5), S. pombe (Sp_C5), C. elegans (Ce_C5), D. 
melanogaster (Dm_C5) and B. taurus (Bt_C5). As, above, sequences were aligned using T-
Coffee, the alignment was prepared using Chimera with the Clustal X colour scheme, and 
the main secondary structural elements are annotated above the alignment according to 
(Robinson et al., 2001). The yellow arrow/dotted line indicates the splicepoint in the C5/C5L 
hybrids. 
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